Elite athletes with COVID-19 : predictors of the course of disease
Deutscher übersetzter Titel: | Spitzensportler mit COVID-19 : Prädiktoren des Krankheitsverlaufs |
---|---|
Autor: | Krzywański, Jarosław; Mikulski, Tomasz; Krysztofiak, Hubert; Pokrywka, Andrzej; Młyńczak, Marcel; Małek, Łukasz A.; Kwiatkowska, Dorota; Kuchar, Ernest |
Erschienen in: | Journal of science and medicine in sport |
Veröffentlicht: | 25 (2022), 1, S. 9-14, Lit. |
Format: | Literatur (SPOLIT) |
Publikationstyp: | Zeitschriftenartikel |
Medienart: | Elektronische Ressource (online) Gedruckte Ressource |
Sprache: | Englisch |
ISSN: | 1440-2440, 1878-1861 |
DOI: | 10.1016/j.jsams.2021.07.003 |
Schlagworte: | |
Online Zugang: | |
Erfassungsnummer: | PU202212008839 |
Quelle: | BISp |
Abstract des Autors
Objectives: The aim of the study was to identify predictors determining the course of COVID-19 and antibody response in elite athletes. Design: Observational study. Methods: Routine medical screening with physical examination, resting ECG, and laboratory tests including antibody response was performed 12–68 days after the diagnosis of COVID-19 in 111 athletes of different sports. Results: Clinical symptoms were observed in 84% of subjects. The severity of COVID-19 was mild in 82% of athletes and moderate in 2% of cases. Athletes aged above 26 and male were more likely to develop symptomatic COVID-19. Asymptomatic subjects were younger and predominantly female. In 18% of subjects, symptoms were still present 20 (12–68) days (median and range) since positive diagnosis. Antibody response was observed in 88% of athletes, and its magnitude correlated with time since diagnosis of COVID-19 (RT-PCR), fatigue, fever, and conjunctivitis. There were no differences in antibody response between groups distinguished by sports discipline (p = 0.50), and sex (p = 0.59), and antibody response did not correlate with BMI (p = 0.12), age (p = 0.13), the number of symptoms (p = 0.43) or their duration (p = 0.19). Conclusions: The severity of COVID-19 in elite athletes is predominantly mild and without complications. Athletes can return to sport after two symptom-free weeks and additional heart screening is usually not required. Determination of antibodies has been shown to be a useful indicator of a previous COVID-19 disease, and some symptoms can be used as predictors of antibody response.